Medical experts reveal alarming risks as patients seek ‘quick fix’ weight loss injections without meeting clinical criteria, with some regaining all lost weight after stopping treatment
Doctors in the United Arab Emirates are warning against the growing off-label use of diabetes medications such as Ozempic and Mounjaro for weight loss, as demand surges among individuals who are neither diabetic nor clinically obese.
Here’s a news-style article based on your headline:
As demand for fast weight loss solutions skyrockets, doctors across the UAE are sounding the alarm on the rising off-label use of Type 2 diabetes medications—Ozempic and Mounjaro—by people seeking to shed pounds quickly.
Originally designed to help manage blood sugar levels, these injectable drugs, known as GLP-1 receptor agonists, have gained viral popularity for their weight loss effects. However, local health professionals caution that using them without proper medical oversight can lead to serious health risks, calling the trend “dangerous” and “misguided.”
From Prescription to Popular Trend
On platforms like TikTok and Instagram, influencers and celebrities have fueled the buzz around Ozempic (semaglutide) and Mounjaro (tirzepatide), showcasing dramatic weight loss stories. In some cases, people without diabetes are obtaining these drugs via online pharmacies or private clinics—despite not being medically approved for weight loss in the UAE unless prescribed under strict criteria.
“People see the before-and-after photos and think it’s a miracle drug,” says Dr. Aisha Al Dhanhani, an endocrinologist at a major Dubai hospital. “But these medications were never meant to be taken without proper evaluation. They’re not a magic solution.”
Growing Supply, Growing Risks
Doctors across the Emirates report a surge in patients requesting the injections solely for weight loss. Some obtain them legally through off-label prescriptions; others turn to the black market, raising concerns about counterfeit products and unsafe usage.
“We are seeing young adults with no history of obesity using these medications for minor weight loss,” says Dr. Fadi Al Nasser, a bariatric specialist in Abu Dhabi. “The problem is that people are skipping medical advice, which increases the risk of serious side effects.”
Side effects can include nausea, vomiting, pancreatitis, gallbladder issues, and even thyroid tumors, according to warnings from the U.S. FDA and other international health authorities.
Regulators and Hospitals Respond
The UAE Ministry of Health and Prevention (MoHAP) has issued reminders to healthcare providers about prescribing guidelines and the importance of patient monitoring. Several private hospitals have also introduced internal protocols limiting how and when these medications are prescribed.
Dr. Samar Younis, a clinical pharmacist in Sharjah, warns of another consequence: “We’re seeing a shortage of supply for patients who actually need the drug for diabetes management. That’s extremely concerning.”
Psychological Impact and Body Image Pressure
Experts also point to a growing mental health dimension. Dr. Lina Farouk, a psychologist based in Dubai, says more young women and men are feeling pressured to use drugs like Ozempic to meet unrealistic body ideals promoted online.
“We’re seeing a shift where people now associate weight loss with injections rather than diet, exercise, or long-term behavior change,” Dr. Farouk explains. “That can create lasting issues with self-esteem and dependency.”
Alternatives and the Need for Education
Doctors advocate for multi-disciplinary approaches to weight management, including nutrition counseling, physical activity, mental health support, and—when necessary—medically supervised interventions.
“There are approved medications for weight loss in the UAE, and bariatric surgery for those who qualify,” says Dr. Al Dhanhani. “But we must remember: health is a marathon, not a sprint.”
Hospitals are now urging patients to consult licensed healthcare providers before starting any injectable treatment, and some clinics are rolling out awareness campaigns on safe weight loss practices.
Key Facts:
- Ozempic and Mounjaro are not officially approved in the UAE for weight loss unless prescribed off-label under a physician’s guidance.
- Misuse can lead to serious side effects, including pancreatitis, thyroid issues, and nutrient malabsorption.
- Healthcare professionals emphasize the importance of long-term, sustainable weight management methods.
- Regulatory bodies and hospitals are urging caution as demand and shortages rise.
Bottom Line: While GLP-1 drugs may offer hope for individuals struggling with obesity, UAE health professionals stress that these medications are not a shortcut—and without medical guidance, they can do more harm than good.
Would you like a shorter version for social media or a pull-quote section for a magazine layout?
